Vir Biotechnology CMO Mark Eisner to step down effective April 24, 2026

Vir Biotechnology, Inc.

Mark Eisner, EVP and Chief Medical Officer, leaving role on April 24, 2026.
Company has initiated search for a successor; no replacement named yet.
Departure disclosed in Item 5.02 of the filing.

item 5.02

Vir Biotechnology, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-26-151209

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.